Back to Search
Start Over
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC
- Source :
- Clinics and Research in Hepatology and Gastroenterology; October 2023, Vol. 47 Issue: 8
- Publication Year :
- 2023
-
Abstract
- •Albumine infusion during Atezolizumab-Bevacizumab in Child-Pugh B patients reduce expansion/development of ascites•Albumine infusion during Atezolizumab-Bevacizumab in Child-Pugh B patients do not improve overall survival•Similar rate of hepatic encephatolopathy and acute variceal bleeding were observed in Child-Pugh B patients who received or not albumin infusion in combination with Atezolizumab-Bevacizumab
Details
- Language :
- English
- ISSN :
- 22107401
- Volume :
- 47
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Clinics and Research in Hepatology and Gastroenterology
- Publication Type :
- Periodical
- Accession number :
- ejs63964902
- Full Text :
- https://doi.org/10.1016/j.clinre.2023.102199